Christos Markopoulos, Professor of Surgery
Christos Markopoulos, Professor of Surgery
National and Kapodistrian University of Athens, Medical School, Athens, Greece
Verified email at - Homepage
Cited by
Cited by
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas, J Ioannovich, U Dafni, C Stavropoulou-Giokas, K Frangia, ...
New England Journal of Medicine 354 (7), 709-718, 2006
Adiponectin and breast cancer risk
C Mantzoros, E Petridou, N Dessypris, C Chavelas, M Dalamaga, ...
The Journal of Clinical Endocrinology & Metabolism 89 (3), 1102-1107, 2004
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial
CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ...
The Lancet 377 (9762), 321-331, 2011
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor–positive breast cancer
W van de Water, C Markopoulos, CJH van de Velde, C Seynaeve, ...
Jama 307 (6), 590-597, 2012
Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.
JC Gazet, HT Ford, RC Coombes, JM Bland, R Sutcliffe, J Quilliam, ...
European journal of surgical oncology 20 (3), 207-214, 1994
Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane …
JMS Bartlett, CL Brookes, T Robson, CJH van de Velde, LJ Billingham, ...
Journal of Clinical Oncology 29 (12), 1531, 2011
Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer
JC Gazet, HT Ford, JM Bland, RC Coombes, RC Dixon
The Lancet 331 (8587), 679-681, 1988
Leptin and insulin growth factor I in relation to breast cancer (Greece)
E Petridou, Y Papadiamantis, C Markopoulos, E Spanos, N Dessypris, ...
Cancer causes & control 11 (5), 383-388, 2000
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, RE Coleman, C Wilson, TJ Powles, P Clézardin, M Aapro, ...
Annals of Oncology 27 (3), 379-390, 2016
Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle
C Markopoulos, UTA Berger, P Wilson, JC Gazet, RC Coombes
Br Med J (Clin Res Ed) 296 (6633), 1349-1351, 1988
Impact of breast cancer surgery on the self-esteem and sexual life of female patients
C Markopoulos, AK Tsaroucha, E Kouskos, D Mantas, Z Antonopoulou, ...
Journal of International Medical Research 37 (1), 182-188, 2009
Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study
VS Sabine, C Crozier, CL Brookes, C Drake, T Piper, CJH van de Velde, ...
Journal of Clinical Oncology 32 (27), 2951-2958, 2014
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized …
G Fountzilas, D Skarlos, U Dafni, H Gogas, E Briasoulis, D Pectasides, ...
Annals of oncology 16 (11), 1762-1771, 2005
Heterogeneous HER2 Gene Amplification: Impact on Patient Outcome and a Clinically Relevant Definition
AI Bartlett, J Starcyznski, T Robson, A MacLellan, FM Campbell, ...
American journal of clinical pathology 136 (2), 266-274, 2011
Bilateral breast cancer.
J Gogas, C Markopoulos, P Skandalakis, H Gogas
The American Surgeon 59 (11), 733-735, 1993
Expression of alpha-thymosins in human tissues in normal and abnormal growth
OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ...
Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc 99 and patent blue in the detection of sentinel node (SN) in patients …
A Karakatsanis, PM Christiansen, L Fischer, C Hedin, L Pistioli, M Sund, ...
Breast cancer research and treatment 157 (2), 281-294, 2016
Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial
C Markopoulos, E Tzoracoleftherakis, A Polychronis, B Venizelos, U Dafni, ...
Breast cancer research 12 (2), 1-12, 2010
The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study
C Markopoulos, A Polychronis, V Zobolas, G Xepapadakis, ...
Breast cancer research and treatment 93 (1), 61-66, 2005
The system can't perform the operation now. Try again later.
Articles 1–20